Hyloris Pharmaceuticals SA (HYL)
EU
Year End December 30 2023 | 2017 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 1.35M | 4.37M | 7.95M | 5.98M | 69.18M | 63.44M | 60.73M | 47.68M |
Total Current Assets | 285k | 502k | 3.84M | 3.74M | 66.61M | 53.96M | 49.8M | 35.31M |
Cash and Equivalents | 224k | 271k | 2.69M | 205k | 64.4M | 50.01M | 33.46M | 30.41M |
Total Non-Current Assets | -2.19M | -4.29M | -4.46M | -10.19M | 59.06M | 48.06M | 53.91M | 39.07M |
Total Liabilities | 3.53M | 8.65M | 12.41M | 16.17M | 10.12M | 15.39M | 6.82M | 8.61M |
Total Current Liabilities | 1.06M | 1.87M | 3.1M | 16.15M | 2.13M | 14.98M | 5.77M | 6.76M |
Total Non-Current Liabilities | 4.94M | 13.56M | 18.62M | 44k | 15.98M | 820k | 1.79M | 3.36M |
Total Equity | -2.19M | -4.29M | -4.46M | -10.19M | 59.06M | 48.06M | 53.91M | 39.07M |
Common Equity | 67k | 79k | 89k | 89k | 129k | 129k | 140k | 140k |
Retained Earnings | -20.67M | -24.32M | -28.1M | -36.08M | -43.23M | -54.81M | -65.38M | -80.76M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.